J M Connors
About
In The Last Decade
J M Connors
16 papers receiving 900 citations
Peers
Comparison fields: 5 of 66
- Pathology and Forensic Medicine 559
- Oncology 392
- Genetics 285
- Molecular Biology 209
- Pulmonary and Respiratory Medicine 193
Countries citing papers authored by J M Connors
This map shows the geographic impact of J M Connors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J M Connors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J M Connors more than expected).
Fields of papers citing papers by J M Connors
This network shows the impact of papers produced by J M Connors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J M Connors. The network helps show where J M Connors may publish in the future.
Co-authorship network of co-authors of J M Connors
This figure shows the co-authorship network connecting the top 25 collaborators of J M Connors. A scholar is included among the top collaborators of J M Connors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J M Connors. J M Connors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | The architectural pattern of FOXP3(+) T cells is an independent predictor of survival in patients with follicular lymphoma (FL) | 6 |
| 3 | 117 | |
| 4 | Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide. | 45 |
| 5 | Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma. | 24 |
| 6 | Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin. | 6 |
| 7 | Bone marrow transplantation in Hodgkin's disease. | 2 |
| 8 | 8 | |
| 9 | 149 | |
| 10 | 33 | |
| 11 | 90 | |
| 12 | 49 | |
| 13 | An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. | 75 |
| 14 | 130 | |
| 15 | 196 | |
| 16 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.